statistiche ricercatore

Continente	#
NA - Nord America	1.501
EU - Europa	874
AS - Asia	571
SA - Sud America	106
AF - Africa	12
Continente sconosciuto - Info sul continente non disponibili	1
OC - Oceania	1
Totale	3.066

Nazione	#
US - Stati Uniti d'America	1.461
DE - Germania	212
SG - Singapore	185
IT - Italia	167
CN - Cina	160
RU - Federazione Russa	113
SE - Svezia	82
BR - Brasile	80
HK - Hong Kong	79
VN - Vietnam	61
FI - Finlandia	59
GB - Regno Unito	54
IE - Irlanda	52
AT - Austria	35
CA - Canada	32
UA - Ucraina	31
TR - Turchia	17
DK - Danimarca	16
FR - Francia	15
IN - India	14
ID - Indonesia	11
IQ - Iraq	9
NL - Olanda	9
AR - Argentina	7
ES - Italia	7
PL - Polonia	7
BE - Belgio	6
EC - Ecuador	6
JP - Giappone	6
ZA - Sudafrica	6
KR - Corea	5
MX - Messico	5
BD - Bangladesh	4
CO - Colombia	4
CL - Cile	3
IL - Israele	3
TW - Taiwan	3
VE - Venezuela	3
AE - Emirati Arabi Uniti	2
CH - Svizzera	2
CZ - Repubblica Ceca	2
DO - Repubblica Dominicana	2
IR - Iran	2
JO - Giordania	2
KZ - Kazakistan	2
LT - Lituania	2
AU - Australia	1
AZ - Azerbaigian	1
BY - Bielorussia	1
CG - Congo	1
DZ - Algeria	1
EU - Europa	1
GT - Guatemala	1
GY - Guiana	1
LA - Repubblica Popolare Democratica del Laos	1
LB - Libano	1
LU - Lussemburgo	1
MN - Mongolia	1
MU - Mauritius	1
NG - Nigeria	1
OM - Oman	1
PE - Perù	1
PT - Portogallo	1
PY - Paraguay	1
SC - Seychelles	1
TN - Tunisia	1
UZ - Uzbekistan	1
Totale	3.066

Nome	#
Inhibition of the Hexosamine Biosynthetic Pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis	618
Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models	356
Characterization of biological features of a rat F98 GBM model: a PET-MRI study with [18F]FAZA and [18F]FDG	294
Imaging Metformin Efficacy as Add-On Therapy in Cells and Mouse Models of Human EGFR Glioblastoma	289
Identification of imaging biomarkers for the assessment of tumour response to different treatments in a preclinical glioma model	283
Validation of an Engineered Cell Model for In Vitro and In Vivo HIF-1α Evaluation by Different Imaging Modalities	264
Metabolic evaluation of non-small cell lung cancer patient-derived xenograft models using 18F-FDG PET: A potential tool for early therapy response	259
Leukocytes recruited by tumor-derived HMGB1 sustain peritoneal carcinomatosis	254
PET imaging as a biomarker of tumor response to therapy	235
Tumour hypoxia: lessons learnt from preclinical imaging	215
PO-259 Inhibition of the hexosamine biosynthetic pathway by targeting PGM3 causes breast cancer growth arrest and apoptosis	121
Totale	3.188

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	147	0	0	0	0	0	32	18	15	18	17	20	27
2021/2022	165	13	16	22	11	5	14	10	10	6	15	13	30
2022/2023	296	30	94	33	28	13	45	13	9	22	2	2	5
2023/2024	192	2	10	7	17	29	56	27	6	14	2	3	19
2024/2025	624	37	43	39	24	58	44	83	47	67	77	42	63
2025/2026	619	137	69	83	152	169	9	0	0	0	0	0	0
Totale													3.188

Bicocca Open Archive